GentleCure

GentleCure, a brand of SkinCure Oncology, provides a non-surgical treatment for non-melanoma skin cancer using Image-Guided Superficial Radiation Therapy (IG-SRT). The company partners with dermatology practices to offer a comprehensive "GentleCure Experience," which includes the Sensus SRT-100 Vision™ device, clinical staffing, and operational support. This technology uses high-frequency ultrasound imaging to visualize tumors and deliver precise, low-dose X-ray energy to destroy cancer cells while sparing healthy tissue. With a reported cure rate of over 99% for early-stage basal and squamous cell carcinomas, GentleCure serves as a painless alternative to Mohs surgery. The company has treated over 140,000 patients across hundreds of dermatology practices in the United States.